Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study
Durmo, Rexhep, Donati, Benedetta, Rebaud, Louis, Cottereau, Anne Segolene, Ruffini, Alessia, Nizzoli, Maria Elena, Ciavarella, Sabino, Vegliante, Maria Carmela, Nioche, Christophe, Meignan, Michel, Merli, Francesco, Versari, Annibale, Ciarrocchi, Alessia, Buvat, Irene, Luminari, Stefano
Published in Hematological oncology (01.10.2022)
Published in Hematological oncology (01.10.2022)
Get full text
Journal Article
18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
Girum, Kibrom B, Rebaud, Louis, Cottereau, Anne-Ségolène, Meignan, Michel, Clerc, Jérôme, Vercellino, Laetitia, Casasnovas, Olivier, Morschhauser, Franck, Thieblemont, Catherine, Buvat, Irène
Published in The Journal of nuclear medicine (1978) (01.12.2022)
Published in The Journal of nuclear medicine (1978) (01.12.2022)
Get full text
Journal Article
18 F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
Girum, Kibrom B, Rebaud, Louis, Cottereau, Anne-Ségolène, Meignan, Michel, Clerc, Jérôme, Vercellino, Laetitia, Casasnovas, Olivier, Morschhauser, Franck, Thieblemont, Catherine, Buvat, Irène
Published in Journal of Nuclear Medicine (01.12.2022)
Published in Journal of Nuclear Medicine (01.12.2022)
Get full text
Journal Article
Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial
Girum, Kibrom B, Cottereau, Anne-Ségolène, Vercellino, Laetitia, Rebaud, Louis, Clerc, Jérôme, Casasnovas, Olivier, Morschhauser, Franck, Thieblemont, Catherine, Buvat, Irène
Published in Journal of Nuclear Medicine (01.02.2024)
Published in Journal of Nuclear Medicine (01.02.2024)
Get full text
Journal Article
Baseline PET Metabolic Tumor Volume Predicts Outcome in Advanced Follicular Lymphoma Patients Who Received First-Line Immunochemotherapy but Not Those Treated with Lenalidomide-Rituximab in the Phase III Relevance Study
Cottereau, Anne Ségolène, Rebaud, Louis, Trotman, Judith, Feugier, Pierre, Nastoupil, Loretta J., Bachy, Emmanuel, Flinn, Ian W., Haioun, Corinne, Ysebaert, Loic, Bartlett, Nancy L., Tilly, Hervé, Casasnovas, René-Olivier, Ricci, Romain, Portugues, Cedric, Buvat, Irène, Meignan, Michel, Morschhauser, Franck
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article